Similarly, in cancers such as melanoma, neuroblastoma, and colon cancer, eATP signaling pharmacological blockade reduces vascular endothelial growth factor (VEGF)-mediated tumor growth [69]. This evidence concerns the gene VEGFA and melanoma.